SFX by Ex Libris Inc.

Title:	HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Source:	Science [0036-8075] Jardine, J G yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Burton, James G. "Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys." Nature 503.7475 (2013): 224-8.
description	2.	Jardine, Joseph G G. "HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen." Science 349.6244 (2015): 156-61.
description	3.	Mouquet, H. "Antibody B cell responses in HIV-1 infection." Trends in immunology 35.11 (2014): 549-561.
description	4.	Jardine, J. "Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors." Science 340.6133 (2013): 1-7.
description	5.	ten Dijke, P. "Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4." The Journal of biological chemistry 269.25 (1994): 16985-8.
description	6.	Shingai, M. "Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia." Nature 503.7475 (2013): 277-80.
description	7.	Haynes, Barton F. "AIDS/HIV. Host controls of HIV neutralizing antibodies." Science 344.6184 (2014): 588-9.
description	8.	Rosenweig, B L L. "Cloning and characterization of a human type II receptor for bone morphogenetic proteins." Proceedings of the National Academy of Sciences of the United States of America 92.17 (1995): 7632-6.
description	9.	Nussenzweig, Florian S. "HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1." Science 352.6288 (2016): 997-1001.
description	10.	Nonner, D. "Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia." Journal of neurochemistry 77.2 (2001): 691-699.
description	11.	Olinger, Gene G. "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.(IMMUNOLOGY)(Author abstract)." Proceedings of the National Academy of Sciences of the United States of America 109.44 (2012): 18030-.
description	12.	Song, R. "Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity." Nature biotechnology 31.11 (2013): 1047-1052.
description	13.	Nussenzweig, Florian C. "Antibodies in HIV-1 vaccine development and therapy." Science 341.6151 (2013): 1199-1204.
description	14.	Ploquin, A. "Protection Against Henipavirus Infection Using Recombinant AAV Vector Vaccines." The Journal of infectious diseases 207.3 (2012): 469-78.
description	15.	Julien, J. "Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA." Immunological reviews 250.1 (2012): 180-198.
description	16.	Diskin, R. "Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design." Science 334.6060 (2011): 1289-1293.
description	17.	Wu, X. "Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing." Science 333.6049 (2011): 1593-1602.
description	18.	Cohen, Myron S. "Prevention of HIV-1 Infection with Early Antiretroviral Therapy." The New England journal of medicine 365.6 (2011): 493-505.
description	19.	Arnott, A. "High Viral Fitness during Acute HIV-1 Infection." PLoS ONE 5.9 (2010): 1-12.
description	20.	Richard, Y. "Changes in blood B cell phenotypes and Epstein‐Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy." The Journal of infectious diseases 202.9 (2010): 1424-1434.